The American Journal of Medicine
Volume 121, Issue 5 , Pages 433-443.e4 , May 2008

Effectiveness of Chronic Obstructive Pulmonary Disease-Management Programs: Systematic Review and Meta-Analysis

  • Isabelle Peytremann-Bridevaux, MD, MPH, DSc

      Affiliations

    • Institute of Social and Preventive Medicine, Healthcare Evaluation Unit, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland
    • Corresponding Author InformationRequests for reprints should be addressed to Isabelle Peytremann-Bridevaux, MD, MPH, DSc, Institute of Social and Preventive Medicine, 17 Bugnon, CH-1005 Lausanne, Switzerland.
    • ,
  • Philippe Staeger, MD, MPH

      Affiliations

    • Department of Ambulatory Care and Community Medicine, University of Lausanne, Lausanne, Switzerland
    • ,
  • Pierre-Olivier Bridevaux, MD, MSc

      Affiliations

    • Division of Pulmonary Care, Department of Medicine, University Hospitals of Geneva, Geneva, Switzerland
    • ,
  • William A. Ghali, MD, MPH

      Affiliations

    • Departments of Medicine and Community Health Sciences, University of Calgary, Calgary, Canada
    • ,
  • Bernard Burnand, MD, MPH

      Affiliations

    • Institute of Social and Preventive Medicine, Healthcare Evaluation Unit, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland
    • Groupe de Recherche en Gestion Thérapeutique, Faculté de Médecine, Université de Montréal, Canada.

References 

  1. Calverley PM, Walker P. Chronic obstructive pulmonary disease. Lancet. 2003;362:1053–1061
  2. Halbert RJ, Natoli JL, Gano A, et al. Global burden of COPD: systematic review and meta-analysis. Eur Respir J. 2006;28:523–532
  3. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet. 1997;349:1498–1504
  4. Celli BR, MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J. 2004;23:932–946
  5. Lindenauer PK, Pekow P, Gao S, et al. Quality of care for patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease. Ann Intern Med. 2006;144:894–903
  6. Mularski RA, Asch SM, Shrank WH, et al. The quality of obstructive lung disease care for adults in the United States as measured by adherence to recommended processes. Chest. 2006;130:1844–1850
  7. Faxon DP, Schwamm LH, Pasternak RC, et al. Improving quality of care through disease management: principles and recommendations from the American Heart Association's Expert Panel on Disease Management. Circulation. 2004;109:2651–2654
  8. Pilnick A, Dingwall R, Starkey K. Disease management: definitions, difficulties and future directions. Bull World Health Organ. 2001;79:755–763
  9. Ellrodt G, Cook DJ, Lee J, et al. Evidence-based disease management. JAMA. 1997;278:1687–1692
  10. DMAA definition of disease management. http://www.dmaa.org/dm_definition.aspAccessed November 24, 2006
  11. Kesteloot K. Disease management (A new technology in need of critical assessment). Int J Technol Assess Health Care. 1999;15:506–519
  12. Ofman JJ, Badamgarav E, Henning JM, et al. Does disease management improve clinical and economic outcomes in patients with chronic diseases? (A systematic review). Am J Med. 2004;117:182–192
  13. Gonseth J, Guallar-Castillon P, Banegas JR, et al. The effectiveness of disease management programmes in reducing hospital re-admission in older patients with heart failure: a systematic review and meta-analysis of published reports. Eur Heart J. 2004;25:1570–1595
  14. McAlister FA, Lawson FM, Teo KK, Armstrong PW. A systematic review of randomized trials of disease management programs in heart failure. Am J Med. 2001;110:378–384
  15. Roccaforte R, Demers C, Baldassarre F, et al. Effectiveness of comprehensive disease management programmes in improving clinical outcomes in heart failure patients (A meta-analysis). Eur J Heart Fail. 2005;7:1133–1144
  16. Badamgarav E, Weingarten SR, Henning JM, et al. Effectiveness of disease management programs in depression: a systematic review. Am J Psychiatry. 2003;160:2080–2090
  17. Neumeyer-Gromen A, Lampert T, Stark K, Kallischnigg G. Disease management programs for depression: a systematic review and meta-analysis of randomized controlled trials. Med Care. 2004;42:1211–1221
  18. Knight K, Badamgarav E, Henning JM, et al. A systematic review of diabetes disease management programs. Am J Manag Care. 2005;11:242–250
  19. Norris SL, Nichols PJ, Caspersen CJ, et al. The effectiveness of disease and case management for people with diabetes (A systematic review). Am J Prev Med. 2002;22:15–38
  20. Rea H, McAuley S, Stewart A, et al. A chronic disease management programme can reduce days in hospital for patients with chronic obstructive pulmonary disease. Intern Med J. 2004;34:608–614
  21. Steuten L, Vrijhoef B, Van MF, et al. Evaluation of a regional disease management programme for patients with asthma or chronic obstructive pulmonary disease. Int J Qual Health Care. 2006;18:429–436
  22. Sin DD, McAlister FA, Man SF, Anthonisen NR. Contemporary management of chronic obstructive pulmonary disease: scientific review. JAMA. 2003;290:2301–2312
  23. Wagner EH, Austin BT, Davis C, et al. Improving chronic illness care: translating evidence into action. Health Aff (Millwood). 2001;20:64–78
  24. Adams SG, Smith PK, Allan PF, et al. Systematic review of the chronic care model in chronic obstructive pulmonary disease prevention and management. Arch Intern Med. 2007;167:551–561
  25. Lacasse Y, Goldstein R, Lassersson TJ, Martin S. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2006;18(4):CD003793
  26. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Control Clin Trials. 1996;17:1–12
  27. Cochrane Handbook for Systematic Reviews of Interventions 4.2.6 [updated September 2006]. The Cochrane Library, Issue 4 ed. Chichester, UK: John Wiley & Sons, Ltd; 2006;
  28. Steuten LM, Vrijhoef HJ, van Merode GG, et al. The Health Technology Assessment-disease management instrument reliably measured methodologic quality of health technology assessments of disease management. J Clin Epidemiol. 2004;57:881–888
  29. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–560
  30. In:  Egger M,  Smith GD,  Altman DG editor. Systematic Reviews and Health Care: Meta-analysis in Context. London: BMJ Publications; 2002;
  31. Review Manager (RevMan) [Computer program]. Version 4.2 for Windows. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration; 2003;
  32. Bourbeau J, Julien M, Maltais F, et al. Reduction of hospital utilization in patients with chronic obstructive pulmonary disease: a disease-specific self-management intervention. Arch Intern Med. 2003;163:585–591
  33. Casas A, Troosters T, Garcia-Aymerich J, et al. Integrated care prevents hospitalisations for exacerbations in COPD patients. Eur Respir J. 2006;28:123–130
  34. Engstrom CP, Persson LO, Larsson S, Sullivan M. Long-term effects of a pulmonary rehabilitation programme in outpatients with chronic obstructive pulmonary disease: a randomized controlled study. Scand J Rehabil Med. 1999;31:207–213
  35. Gadoury MA, Schwartzman K, Rouleau M, et al. Self-management reduces both short- and long-term hospitalisation in COPD. Eur Respir J. 2005;26:853–857
  36. Guell R, Casan P, Belda J, et al. Long-term effects of outpatient rehabilitation of COPD: a randomized trial. Chest. 2000;117:976–983
  37. Monninkhof E, van der Valk P, van der Palen J, et al. Effects of a comprehensive self-management programme in patients with chronic obstructive pulmonary disease. Eur Respir J. 2003;22:815–820
  38. Poole PJ, Chase B, Frankel A, Black PN. Case management may reduce length of hospital stay in patients with recurrent admissions for chronic obstructive pulmonary disease. Respirology. 2001;6:37–42
  39. Ries AL, Kaplan RM, Myers R, Prewitt LM. Maintenance after pulmonary rehabilitation in chronic lung disease: a randomized trial. Am J Respir Crit Care Med. 2003;167:880–888
  40. Soler JJ, Martinez-Garcia MA, Roman P, et al. Effectiveness of a specific program for patients with chronic obstructive pulmonary disease and frequent exacerbations. Arch Bronconeumol. 2006;42:501–508
  41. Tinkelman D, Corsello P, McCulloch D, Yusuf S. One-year outcomes from a disease management program for chronic obstructive pulmonary disease. Dis Manage Health Outcomes. 2003;11:49–59
  42. Wijkstra PJ, Ten Vergert EM, van AR, et al. Long term benefits of rehabilitation at home on quality of life and exercise tolerance in patients with chronic obstructive pulmonary disease. Thorax. 1995;50:824–828
  43. Wijkstra PJ, van der Mark TW, Kraan J, et al. Long-term effects of home rehabilitation on physical performance in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1996;153:1234–1241
  44. Zajac B. Measuring outcomes of a chronic obstructive pulmonary disease management program. Dis Manage. 2002;5:9–23
  45. Gross NJ. Chronic obstructive pulmonary disease outcome measurements: what's important? What's useful?. Proc Am Thorac Soc. 2005;2:267–271
  46. Calverley PM, Anderson JA, Celli B, et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med. 2007;356:775–789
  47. Weingarten SR, Henning JM, Badamgarav E, et al. Interventions used in disease management programmes for patients with chronic illness-which ones work? (Meta-analysis of published reports). BMJ. 2002;325:925
  48. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (updates 2007). http://www.goldcopd.orgAccessed January 10, 2008

 Dr Isabelle Peytremann-Bridevaux is supported by a grant from the Bourse de la commission pour la promotion académique des femmes, faculté de biologie et médecine de l'université de Lausanne.

PII: S0002-9343(08)00177-0

doi: 10.1016/j.amjmed.2008.02.009

The American Journal of Medicine
Volume 121, Issue 5 , Pages 433-443.e4 , May 2008

Article Tools

* Image Usage & Resolution